Home  |  Contact

Cellosaurus SW1990/ADM (CVCL_ZW96)

[Text version]
Cell line name SW1990/ADM
Accession CVCL_ZW96
Resource Identification Initiative To cite this cell line use: SW1990/ADM (RRID:CVCL_ZW96)
Comments Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
Sequence variations
  • Mutation; HGNC; 27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; 11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
Disease Pancreatic adenocarcinoma (NCIt: C8294)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1723 (SW1990)
Sex of cell Male
Age at sampling 56Y
Category Cancer cell line
Publications

PubMed=17217822; DOI=10.3760/j.issn.0529-5815.2006.19.016
Bu G.-B., Zhao Y.-P., Chen G., Zhang T.-P., Li L.-J., Wu Y.-D.
Expression and significance of GCS gene in human pancreatic cancer cell SW1990 and its drug-resistant sublines.
Zhonghua Wai Ke Za Zhi 44:1342-1344(2006)

Cross-references
Cell line databases/resources cancercelllines; CVCL_ZW96
Encyclopedic resources Wikidata; Q102114954
Entry history
Entry creation29-Oct-2020
Last entry update05-Oct-2023
Version number6